News Search Results
Jul 12, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
[Click here for information about joining the class action] PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
More news about: Pomerantz LLP
Jul 12, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD
Medicine Program focuses on "the use of additive manufacturing for human organ transplantation." Since 2018, 3D Systems has partnered with the biotechnology company United Therapeutics Corporation ("United") "with a long-term goal of developing the capability to 3D print lungs that will allow patients
More news about: Pomerantz LLP
Jul 11, 2025, 11:00 ET High-Speed Cable Market Size to Reach USD 24.99 billion in 2031, Growing at a CAGR of 10.2%, | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 11, 2025, 06:55 ET Personal Care Ingredients Market worth $17.00 billion by 2030 - Exclusive Report by MarketsandMarkets™
lifestyles and the rise of e-commerce, is contributing to increased product adoption across diverse geographies and demographics. Innovations in biotechnology, green chemistry, and cold processing technologies are facilitating the development of high-performance ingredients that align with clean beauty
More news about: MarketsandMarkets
Jul 10, 2025, 14:55 ET LevEllis, Inc. Announces the Launch of PROVOQUE™: A Revolutionary Regenerative Skincare Serum
PROVOQUE™, a groundbreaking regenerative skincare serum. This innovative physician dispensed medical grade skincare product utilizes advanced biotechnology to restore, repair, and renew the skin, setting a new standard in the skincare industry.
More news about: LevEllis
Jul 10, 2025, 11:54 ET REGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Microdystrophin Construct in RGX-202 Investigational Gene Therapy for Duchenne Muscular Dystrophy
and independence, required support for breathing, cardiomyopathy and premature death. ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Jul 10, 2025, 11:42 ET Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
standardized process development and manufacturing operations. About IGI IGI is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. Headquartered in New York, NY, IGI is advancing
More news about: Ichnos Glenmark Innovation
Jul 10, 2025, 11:23 ET Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
standardized process development and manufacturing operations. About IGI IGI is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. Headquartered in New York, NY, IGI is advancing
More news about: Ichnos Glenmark Innovation
Jul 10, 2025, 11:00 ET BrainXell, Inc. Appoints Katherine Vega Stultz as Chief Executive Officer and Board Director
Wis., July 10, 2025 /PRNewswire/ -- BrainXell, Inc., a leading biotechnology company developing iPSC-based CNS disease models and regenerative cell therapies, announces the appointment of Katherine
More news about: BrainXell, Inc.
Jul 10, 2025, 10:07 ET Diagnostics Transformed: $37 Billion Immunoassay Market Evolves with AI, Miniaturization, and POC Growth, reports Kalorama Information
Group Inc., has been a trusted source of market intelligence in healthcare diagnostics for over 25 years. With a focus on in vitro diagnostics, biotechnology, medical devices, and pharmaceuticals, Kalorama is recognized for delivering evidence-based insights that inform global business strategies. Kalorama
More news about: Kalorama Information
Jul 10, 2025, 09:15 ET Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year
the world. Illumina ranked second overall in the United States, and third in the global Pharmaceuticals & Biotechnology Industry category. According to TIME's methodology, selections were based on more than 20 key performance indicators related to environmental,
More news about: Illumina, Inc.
Jul 10, 2025, 08:54 ET LG Debuts Next-Generation Precision Medical AI
pharmaceutical and biotech firms to drive innovation in AI-based drug development. LG Corporation Chairman and CEO Kwang-mo Koo has identified AI and biotechnology as strategic growth areas central to improving human health. Reflecting this vision, LG is accelerating efforts in AI–bio convergence through targeted
More news about: LG AI RESEARCH
Jul 10, 2025, 08:30 ET BRENIG THERAPEUTICS ANNOUNCES APPOINTMENTS OF DAVID L. LUCCHINO AS CEO AND TIEN DAM, M.D., AS CHIEF MEDICAL OFFICER, EXPANDS PIPELINE
Mass., July 10, 2025 /PRNewswire/ -- Brenig Therapeutics, a clinical-stage biotechnology company pioneering AI-powered small-molecule therapies for neurodegenerative diseases, today announced two key executive appointments. David
More news about: Brenig Therapeutics Inc.
Jul 10, 2025, 08:30 ET Oncolytics Biotech® to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers
approximately 50 clinical trials and authored over 120 manuscripts. About Oncolytics Biotech Inc.Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Jul 10, 2025, 08:00 ET Kodiak Sciences to Host Investor R&D Day on July 16, 2025
July 10, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing, and commercializing transformative therapeutics, announced today it will host an investor R&D
More news about: Kodiak Sciences Inc.
Jul 10, 2025, 08:00 ET Transcend Therapeutics Receives Breakthrough Therapy Designation for TSND-201 (methylone) for the Treatment of PTSD
Transcend Therapeutics, a clinical-stage biotechnology company that develops medicines to treat neuropsychiatric diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted
More news about: Transcend Therapeutics
Jul 10, 2025, 07:30 ET AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
standardized process development and manufacturing operations. About IGI IGI is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. Headquartered in New York, NY, IGI is advancing
More news about: AbbVie
Jul 10, 2025, 07:00 ET Earendil Labs announces initiation of a phase 1 study of a half-life extended novel anti-TL1A antibody
Del., July 10, 2025 /PRNewswire/ -- Earendil Labs, an AI-empowered biotechnology company, announced that it has completed cohort 1 dosing in a phase 1 trial for a novel anti-TL1A antibody (HXN-1001). The phase 1 study is designed
More news about: Earendil Labs
Jul 10, 2025, 06:00 ET Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on FSHD (Facioscapulohumeral Muscular Dystrophy) using universal iPS cells
facilitating the development and clinical use of therapies based on these cells. Vita Therapeutics Vita Therapeutics is a biotechnology company developing state-of-the-art cellular therapeutics for the treatment of debilitating neuromuscular diseases. Vita Therapeutics uses induced
More news about: I Peace, Inc.; VITA Theraputics
Jul 10, 2025, 05:11 ET Syngene International announces third year of STEM scholarship and mentorship program for women in collaboration with RICH
from low-income or financially underserved families. Their learning journey will conclude with project-based internships with pharmaceutical and biotechnology companies across India, as well as premier government research institutions such as the Council of Scientific and
More news about: Syngene International Ltd.
Jul 09, 2025, 21:09 ET Cathay Financial Holdings dan Cathay United Bank Raih Delapan Penghargaan di Ajang Asian Banking & Finance Awards
Capital untuk meluncurkan private securities investment trust fund pertama di Taiwan yang berfokus pada biotechnology private equity funds -- menyediakan beragam peluang investasi. Dengan big data analytics yang menyatukan kanal layanan daring dan luring,
More news about: Cathay United Bank
Jul 09, 2025, 17:45 ET Pioneering alliance between The Jackson Laboratory and The New York Stem Cell Foundation ushers in new era of predictive biomedical research
breakthroughs translate into real-world treatments, combining academic expertise in scientific research with the translational strengths of the biotechnology and pharmaceutical sectors. "This is a transformative moment," said Lon Cardon, Ph.D., FMedSci, president
More news about: The Jackson Laboratory
Jul 09, 2025, 17:16 ET Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop
Rocket Pharmaceuticals, headquartered in Cranbury, New Jersey, is a biotechnology company focused on developing gene therapies for rare diseases. The suit alleges that the Company failed to inform investors
More news about: Berger Montague
Jul 09, 2025, 13:32 ET BCC Research Releases 2024 Protein Synthesis Research Review
"Driving Innovation and Sustainability: The Vital Role of Protein Synthesis in Modern Biotechnology and Its Impact on Chronic Disease Treatment, Technological Advances, and Market Growth" BOSTON,
More news about: BCC Research LLC
Jul 09, 2025, 12:00 ET Melissa DiMercurio to Lead Skill Accelerator Badge Program at Hood College
most can be applied toward a future master's degree or certificate. Courses are short and fully online for flexibility, with focus areas including biotechnology, business, computing, counseling and trauma, equity and inclusion, education and more. Skill Accelerator badges are verified, digital, competency-based
More news about: Hood College